President Donald Trump signs an executive order reclassifying marijuana as a less dangerous drug in the Oval Office of the White House, Thursday, Dec. 18, 2025, in Washington. (AP Photo/Evan Vucci)
For decades, marijuana has occupied a strange place in American politics. It is widely used and culturally mainstream, yet under federal law it has long been treated like a hard narcotic. Now, in a move that would have been unthinkable during the Reagan-era “war on drugs”, President Donald Trump wants the federal government to ease its stance on cannabis users. The aim is not to legalise or celebrate marijuana, but to stop treating it as if it belongs in the same legal category as heroin. Here’s what that actually means, and what it does not.
What exactly has Trump announced?
Trump has directed federal agencies to relax restrictions on marijuana and expand access to CBD, the non-intoxicating compound derived from cannabis that is commonly used for pain relief, epilepsy treatment, and anxiety management.The most consequential part of the move is his support for reclassifying marijuana under federal law. Currently, cannabis is listed as a Schedule I drug, a category reserved for substances deemed highly addictive with no accepted medical use. Think heroin or LSD.Trump wants marijuana shifted to Schedule III, placing it alongside regulated prescription drugs like ketamine or codeine-based painkillers.
Does this mean marijuana is now legal in the US?
No. And Trump has been explicit about that. Marijuana would remain illegal under federal law. This is not decriminalisation, let alone legalisation. Federal trafficking laws still apply, and states that restrict cannabis can continue to enforce their own laws.What changes is the tone and priority of federal enforcement, especially against users and medical research institutions.In short: Washington is backing off. It is not giving a green light.Why does reclassification matter so much?Because Schedule I status has acted like a scientific chokehold.Researchers studying marijuana currently face layers of red tape that make large-scale, credible medical studies extremely difficult. Moving cannabis to Schedule III would make medical research far easier, allowing doctors and scientists to study its effects without navigating bureaucratic minefields.There is also a financial angle. Cannabis companies have long been denied standard tax deductions because the federal government technically treats them as drug traffickers. Reclassification would allow them to deduct business expenses, offering major relief to an industry that is legal in many states but punished at the federal level.
What about CBD?
Trump’s move also expands access to CBD-based treatments, including a pilot programme allowing Medicare beneficiaries to be reimbursed for certain CBD therapies.CBD does not produce a high. It is already widely used for managing chronic pain, cancer-related symptoms, and neurological disorders. But its legal status has remained murky, especially after recent legislation threatened tighter crackdowns on cannabinoid products.The administration has asked Congress to clarify regulations so that medical CBD remains legally available, rather than being swept up in drug enforcement dragnet logic.
Why is this politically significant?
Because it marks a Republican break from drug-war orthodoxy.For decades, conservative politics treated marijuana as a moral failing and a gateway menace. Trump’s stance reflects a reality that voters already live with: cannabis is mainstream, medical, and legal in most of the country at the state level.More than 40 states allow medical marijuana. Nearly half permit recreational use. Federal policy was the outlier.This is also a rare case of continuity. The push to reclassify marijuana began under the Biden administration. Trump is choosing to finish it.
Who is opposing the move?
Some conservatives argue that easing restrictions sends the wrong message to young people and risks normalising drug use. Others warn that reclassification could complicate FDA oversight, especially since marijuana products are often marketed in edible or lifestyle-friendly forms.Public health experts are also cautious. While marijuana has medical benefits, evidence remains mixed for certain conditions, and long-term effects are still being studied.Trump’s answer, characteristically, is pragmatic rather than philosophical: study it properly, regulate it better, and stop pretending it’s something it isn’t.
The big picture
This is not a cultural revolution. It is a bureaucratic correction.Marijuana is no longer being treated as a Cold War-era bogeyman. The federal government is slowly aligning with medical science, state laws, and social reality.In classic Trump fashion, it is framed not as a moral pivot, but as common sense. The war rhetoric fades. The paperwork changes. And the user, for once, is not the enem Go to Source